Research & Development

Research & Development

Research, Instrumentation & New Product Development

We actively exploring the development of new diagnostic and therapeutic radiopharmaceuticals. By expanding our research into advanced PET tracers and emerging therapeutic isotopes, we aim to broaden clinical applications and enhance patient care. These new initiatives reflect our commitment to delivering innovative solutions that address evolving medical needs in diagnostics and targeted therapies.

Image
Image
Image

About

HKCL specialize in developing and producing high-quality Positron Emission Tomography (PET) radiopharmaceuticals, such as Fluorodeoxyglucose (18F-FDG), Prostate-Specific Membrane Antigen (18F-PSMA), and F-Flutemetamol (18F-FMM).

Links

Contact

G12 & 13, Biotech Centre 2, No.11 Science Park West Avenue, Hong Kong Science Park, Shatin, N. T.

(852) 2332 0989

(852) 2332 0979

Hong Kong Cyclotron Laboratories Limited © 2025. All Right Reserved.